Authors:
Edwards, RM
Contino, LC
Gellai, M
Brooks, DP
Citation: Rm. Edwards et al., Parathyroid hormone-1 receptor down-regulation in kidneys from rats with chronic renal failure, PHARMACOL, 62(4), 2001, pp. 243-247
Citation: Rm. Edwards et Dp. Brooks, Dopamine inhibits vasopressin action in the rat inner medullary collectingduct via alpha(2)-adrenoceptors, J PHARM EXP, 298(3), 2001, pp. 1001-1006
Authors:
Butter, S
Laping, NJ
Pullen, M
Grygielko, E
Olson, B
Brooks, DP
Citation: S. Butter et al., The role of transforming growth factor-beta and its receptors in human prostate smooth muscle cell fibronectin production, EUR J PHARM, 422(1-3), 2001, pp. 47-52
Authors:
Behr, TM
Nerurkar, SS
Nelson, AH
Coatney, RW
Woods, TN
Sulpizio, A
Chandra, S
Brooks, DP
Kumar, S
Lee, JC
Ohlstein, EH
Angermann, CE
Adams, JL
Sisko, J
Sackner-Bernstein, JD
Willette, RN
Citation: Tm. Behr et al., Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction, CIRCULATION, 104(11), 2001, pp. 1292-1298
Authors:
Barone, FC
Coatney, RW
Chandra, S
Sarkar, SK
Nelson, AH
Contino, LC
Brooks, DP
Campbell, WG
Ohlstein, EH
Willette, RN
Citation: Fc. Barone et al., Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats, CARDIO RES, 50(3), 2001, pp. 525-537
Authors:
Wong, VY
Laping, NJ
Nelson, AH
Contino, LC
Olson, BA
Gygielko, E
Campbell, WG
Barone, F
Brooks, DP
Citation: Vy. Wong et al., Renoprotective effects of carvedilol in hypertensive-stroke prone rats mayinvolve inhibition of TGF beta expression, BR J PHARM, 134(5), 2001, pp. 977-984
Authors:
Wong, VY
Laping, NJ
Contino, LC
Olson, BA
Grygielko, E
Brooks, DP
Citation: Vy. Wong et al., Gene expression in rats with renal disease treated with the angiotensin IIreceptor antagonist, eprosartan, PHYSIOL GEN, 4(1), 2000, pp. 35-42
Citation: Dp. Brooks et Pd. Depalma, Unmasking of endothelin-1-induced natriuresis and renal vasodilation in time dog by enrasentan (SB 217242), J CARDIO PH, 36, 2000, pp. S346-S347
Authors:
Parameswaran, N
Aiyar, N
Wu, HL
Brooks, DP
Nambi, P
Spielman, WS
Citation: N. Parameswaran et al., Desensitization and resensitization of adrenomedullin-sensitive receptor in rat mesangial cells, EUR J PHARM, 407(3), 2000, pp. 205-210
Authors:
Parameswaran, N
Disa, J
Spielman, WS
Brooks, DP
Nambi, P
Aiyar, N
Citation: N. Parameswaran et al., Activation of multiple mitogen-activated protein kinases by recombinant calcitonin gene-related peptide receptor, EUR J PHARM, 389(2-3), 2000, pp. 125-130
Authors:
Parameswaran, N
Nambi, P
Hall, CS
Brooks, DP
Spielman, WS
Citation: N. Parameswaran et al., Adrenomedullin decreases extracellular signal-regulated kinase activity through an increase in protein phosphatase-2A activity in mesangial cells, EUR J PHARM, 388(2), 2000, pp. 133-138
Authors:
Kumar, JM
Brooks, DP
Olson, BA
Laping, NJ
Citation: Jm. Kumar et al., Sgk, a putative serine/threonine kinase, is differentially expressed in the kidney of diabetic mice and humans, J AM S NEPH, 10(12), 1999, pp. 2488-2494
Citation: Dp. Brooks et Rr. Ruffolo, Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure, J HYPERTENS, 17, 1999, pp. S27-S32
Authors:
Parameswaran, N
Nambi, P
Brooks, DP
Spielman, WS
Citation: N. Parameswaran et al., Regulation of glomerular mesangial cell proliferation in culture by adrenomedullin, EUR J PHARM, 372(1), 1999, pp. 85-95
Authors:
Parameswaran, N
Spielman, WS
Brooks, DP
Nambi, P
Citation: N. Parameswaran et al., SB203580 reverses adrenomedullin's effect on proliferation and apoptosis in cultured mesangial cells, EUR J PHARM, 371(1), 1999, pp. 75-82
Authors:
Parameswaran, N
Spielman, WS
Pullen, M
Francis, J
Brooks, DP
Nambi, P
Citation: N. Parameswaran et al., Mechanism of adrenomedullin-stimulated hyaluronic acid release in rat mesangial cells, EUR J PHARM, 370(3), 1999, pp. 313-318
Authors:
Feild, JA
Zhang, L
Brun, KA
Brooks, DP
Edwards, RM
Citation: Ja. Feild et al., Cloning and functional characterization of a sodium-dependent phosphate transporter expressed in human lung and small intestine, BIOC BIOP R, 258(3), 1999, pp. 578-582
Citation: Dp. Brooks et al., Pharmacology of eprosortan, an angiotensin II receptor antagonist: Exploring hypotheses from clinical data, AM HEART J, 138(3), 1999, pp. S246-S251